Abivax SA (FR:ABVX)
PARIS:ABVX
Holding FR:ABVX?
Track your performance easily

Abivax SA (ABVX) Financial Statements

13 Followers

Abivax SA Financial Overview

Abivax SA's market cap is currently ―. The company's EPS TTM is €-3.281; its P/E ratio is -2.93; Abivax SA is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is €-0.65. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Dec 23Sep 23Jun 23Dec 22
Income Statement-
Total Revenue--€ 688.00M€ 438.00M-
Gross Profit--€ 688.00M€ 312.00M-
EBIT-----
EBITDA-----
Net Income Common Stockholders--€ -77.00M€ 460.00M-
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments€ 632.00M€ 251.94M€ 244.00M€ 127.00M€ 26.95M
Total Assets€ 7.08B€ 327.06M€ 6.89B€ 7.02B€ 75.54M
Total Debt€ 2.63B€ 55.47M€ 2.83B€ 2.85B€ 19.83M
Net Debt€ 1.99B€ -196.48M€ 2.59B€ 2.72B€ -7.12M
Total Liabilities€ 4.51B€ 131.05M€ 4.53B€ 4.56B€ 68.36M
Stockholders Equity€ 2.51B€ 196.01M€ 2.28B€ 2.35B€ 7.19M
Cash Flow-
Free Cash Flow€ -399.00M-€ 141.00M€ -340.00M-
Operating Cash Flow€ -399.00M-€ 181.00M€ -283.00M-
Investing Cash Flow€ -240.00M-€ -70.00M€ -77.00M-
Financing Cash Flow€ -364.00M-€ -62.00M€ -511.00M-
Currency in EUR

Abivax SA Earnings and Revenue History

Abivax SA Debt to Assets

Abivax SA Cash Flow

Abivax SA Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis